Wonseok Kang
机构：Samsung Medical Center, Sungkyunkwan University · ORCID：0000-0001-9578-8424
发表论文 209 篇 · 总被引 4044 次 · h-index 35
代表论文
- Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial (2025 · The Lancet. Gastroenterology & hepatology · 被引 23)
- Noncontrast Magnetic Resonance Imaging vs Ultrasonography for Hepatocellular Carcinoma Surveillance: A Randomized, Single-Center Trial (2025 · Gastroenterology · 被引 22)
- NADPH oxidase 4 deficiency promotes hepatocellular carcinoma arising from hepatic fibrosis by inducing M2-macrophages in the tumor microenvironment (2024 · Scientific Reports · 被引 10)
- Serum Ferritin Levels and Liver‐Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study (2024 · Alimentary Pharmacology & Therapeutics · 被引 9)
- Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma (2024 · Gut and Liver · 被引 9)
- Molecular landscape of tumor-associated tissue-resident memory T cells in tumor microenvironment of hepatocellular carcinoma (2025 · Cell Communication and Signaling · 被引 8)